More News! 20 Jun 2017 Belgian Llama Antibody Developer gets Second Preclinical Milestone from Danish Pharma …Pharma teamed up to develop antibodies to counter inflammatory diseases in a deal totalling €105M. argenx just received its second preclinical milestone for granting Leo access to its preclinical candidate,… June 20, 2017 - 1 minutemin - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
Interview 9 Oct 2017 The Woman Developing the Next Generation of Cancer Immunotherapy …so far and putting its unique antibody technology one step closer to patients. As she continues at Ganymed by supporting the new owners in their takeover of late-stage antibody development,… October 9, 2017 - 8 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 8 Mar 2017 Which European Blockbusters Topped the Charts in 2016? …is a monoclonal antibody used to treat breast cancers, which are HER2–positive. The antibody binds to the HER2 receptor overexpressed on some breast cancers, thereby inhibiting the proliferation of these… March 8, 2017 - 4 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 6 Sep 2017 Tiziana‘s Antibody Formulation Enters Phase IIa Trial for Liver Disease Treatment Tiziana makes moves towards a €37B market with an oral monoclonal antibody (mAb) formulation to treat non-alcoholic steatohepatitis (NASH) . Tiziana, which has previously developed compounds targeting the second most… September 6, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
More News! 14 Dec 2017 New Biotech in Oxford Takes on Arthritis of the Spine …for the trial, expected to start in the first half of 2018. Namilumab is a human antibody that targets granulocyte macrophage-colony stimulating factor (GM-CSF). The antibody was originally developed by… December 14, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 6 Dec 2022 Pictor receives $5M in funding for Covid antibody test and human and animal portfolios …company announced it had received confirmation of CE registration for its PictArray SARS-CoV-2 IgG enzyme-linked immunosorbent assay (ELISA) antibody test as per in vitro diagnostic directive (IVDD) regulations. CE registration… December 6, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 20 Sep 2022 Collaboration to develop new glioblastoma combination therapy nets €1.06M …by Amsterdam UMC and will help CimCure to study passive immunization. Additionally, Covalab will develop full-length and antibody fragments, to be used for CAR-T cells. This novel approach to antibody… September 20, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 24 Jul 2018 Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug” …Aduro believes its drug candidate can be combined with immune checkpoint inhibitors to induce immunity. Hans van Eenennaam: Our lead antibody program, targeting the APRIL gene, a key driver in… July 24, 2018 - 6 minutesmins - By Editorial Team Share WhatsApp Twitter Linkedin Email
News and Trends 6 Apr 2020 UK Biotech’s Arthritis Drug Enters Study in Coronavirus Patients …we can prevent or reduce deterioration in Covid-19 patients for which there are currently few treatments available.” Izana’s antibody therapy is a human monoclonal antibody targeting GM-CSF and is in… April 6, 2020 - 2 minutesmins - By David Kirk Share WhatsApp Twitter Linkedin Email
Interview 11 Sep 2017 Meet the CEO of Europe’s Largest & Most Fiercely Independent Biotech …example, a bispecific antibody, we can do this in-house. We’ve been able to create two completely new next-generation antibody technology platforms, DuoBody and HexaBody for bispecific and immune effector function… September 11, 2017 - 8 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 6 Dec 2016 How is European Immuno-Oncology fighting Blood Cancer? …also announced Phase I results for IPH4102, a humanized monoclonal antibody to treat cutaneous T-cell lymphomas (CTCL), a subtype of non-Hodgkin’s lymphoma. Argenx, in the Netherlands, has two antibody… December 6, 2016 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 20 Oct 2022 AbbVie acquires LifeArc portfolio company DJS Antibodies AbbVie has acquired LifeArc’s portfolio company DJS Antibodies Limited, a privately-held UK-based biotechnology company dedicated to discovering and developing antibody medicines that target difficult-to-drug disease-causing proteins, such as G protein-coupled… October 20, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email